Does HE4 have a role as biomarker in the recurrence of ovarian cancer?

Carcinoma of the Ovary

APM Heintz, Franco Odicino, Patrick Maisonneuve et al. · International Journal of Gynecology & Obstetrics · 2006 · 1.3K citations

Medicine, Gynecology, Oncology +10

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

Ingegerd Hellström, John Raycraft, Martha Hayden-Ledbetter et al. · PubMed · 2003 · 719 citations

Life Sciences, Molecular Biology, Oncology +17

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass

Richard G. Moore, Amy Brown, Michael Craig Miller et al. · Gynecologic Oncology · 2007 · 693 citations

Medicine, Gynecology, Oncology +16

Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial

Gordon Rustin, Maria EL van der Burg, Clare Griffin et al. · The Lancet · 2010 · 594 citations · Full text

Medicine, Gynecology, Oncology +15

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

Richard G. Moore, Moune Jabre-Raughley, Amy Brown et al. · American Journal of Obstetrics and Gynecology · 2010 · 357 citations

Medicine, Gynecology, Oncology +15